PSYENCE BIOMEDICAL LTD. - Common Shares (PBM)

CUSIP: 74449F308

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Shares
Shares outstanding
1,022,682
Total 13F shares
41,956
Share change
-133,398
Total reported value
$31,700
Price per share
$0.75
Number of holders
4
Value change
-$697,282
Number of buys
3
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 74449F308?
CUSIP 74449F308 identifies PBM - PSYENCE BIOMEDICAL LTD. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PBM - PSYENCE BIOMEDICAL LTD. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Parallel Advisors, LLC
13F
Company
mixed-class rows
178,750
mixed-class rows
$687,368 30 Sep 2025
13F
Hudson Bay Capital Management LP
13D/G
5%
237,768
$133,150 -$79,650 31 Mar 2025
Virtu Financial LLC
13F
Company
1%
10,325
$33,000 30 Sep 2025
13F
Harraden Circle Investments, LLC
13F
Company
class O/S missing
1,150,000
$28,980 30 Sep 2025
13F
Polar Asset Management Partners Inc.
13F
Company
class O/S missing
733,000
$18,472 30 Sep 2025
13F
AdvisorShares Investments LLC
13F
Company
0.53%
5,378
$17,210 30 Sep 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
mixed-class rows
104,500
mixed-class rows
$16,355 30 Sep 2025
13F
MMCAP International Inc. SPC
13F
Company
class O/S missing
600,000
$15,120 30 Sep 2025
13F
AdvisorShares Trust
13D/G
0.79%
26,924
$15,077 $0 31 Dec 2024
TORONTO DOMINION BANK
13F
Company
class O/S missing
503,312
$12,583 30 Sep 2025
13F
Calamos Advisors LLC
13F
Company
class O/S missing
500,000
$12,500 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.33%
3,340
$10,688 30 Sep 2025
13F
Clear Street Group Inc.
13F
Company
class O/S missing
366,565
$9,237 30 Sep 2025
13F
Saba Capital Management, L.P.
13F
Company
class O/S missing
297,847
$7,506 30 Sep 2025
13F
ARISTEIA CAPITAL, L.L.C.
13F
Company
class O/S missing
247,857
$6,432 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
class O/S missing
200,117
$5,043 30 Sep 2025
13F
LMR Partners LLP
13F
Company
class O/S missing
200,000
$5,040 30 Sep 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
class O/S missing
175,352
$4,384 30 Sep 2025
13F
TENOR CAPITAL MANAGEMENT Co., L.P.
13F
Company
class O/S missing
150,000
$3,780 30 Sep 2025
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
class O/S missing
147,101
$3,706 30 Sep 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
class O/S missing
107,909
$2,698 30 Sep 2025
13F
Westchester Capital Management, LLC
13F
Company
class O/S missing
92,073
$2,302 30 Sep 2025
13F
Stonehage Fleming Financial Services Holdings Ltd
13F
Company
0.05%
561
$1,795 30 Sep 2025
13F
Mint Tower Capital Management B.V.
13F
Company
class O/S missing
50,000
$1,000 30 Sep 2025
13F
LPL Financial LLC
13F
Company
class O/S missing
29,345
$739 30 Sep 2025
13F
Ancora Advisors LLC
13F
Company
class O/S missing
5,000
$126 30 Sep 2025
13F
UBS Group AG
13F
Company
class O/S missing
455
$11 30 Sep 2025
13F

Institutional Holders of PSYENCE BIOMEDICAL LTD. - Common Shares (PBM) as of Q4 2025

As of 31 Dec 2025, PSYENCE BIOMEDICAL LTD. - Common Shares (PBM) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,956 shares. The largest 4 holders included Virtu Financial LLC, BANK OF AMERICA CORP /DE/, UBS Group AG, and Stonehage Fleming Financial Services Holdings Ltd. This page lists 4 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
6
Q4 2025 holders
4
Holder diff
-2
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.